Pharmaceutical manufacturers that engage with a patient hub early on are able to collect valuable data on patients via the hub before they begin their treatment. While both patient hubs and SPs collect important patient information, patient hubs can play an integral role in data analysis, providing valuable insights back to manufacturers to inform and enhance ongoing patient engagement strategies. By bringing together SP and program data at the patient hub, biopharma sponsors can get a more complete picture of the patient journey. A patient hub may also be able to marry together patient segmentation and other data sources to paint a more insightful and actionable picture of the patient.
With a patient hub and SP working as partners, patients are able to experience end-to-end support throughout their treatment journey. In order for achieve optimal support levels and reduce operational inefficiencies, bi-directional data contracts should be established at the beginning of the relationship. This ensures the patient hub and SP have the latest information and can deliver aligned support when communicating with the patient.
Successfully bridging the gap between a patient hub and the SP will benefit the patients and the manufacturer alike. Biopharmaceutical companies have an opportunity to expand their services to patients by bringing SPs and their patient hub team to the table for integrated solutions. With the combined educational, data and support resources, an SP and patient hub collaboration on behalf of biopharmaceutical companies can help to set patients on the path to the best outcomes. Aggregating data and sharing valuable insights into each patient’s journey enables both parties to better serve and support patients, and ultimately helps to inform manufacturers on their patient population.
Jon Kwiatkowski, Director of Pharmacy Service, Sonexus™ Access & Patient Support, Cardinal Health